Anticardiolipin antibodies in HIV-negative and HIV-positive haemophiliacs

N Naimi1, C Plancherel, C Bosser

  • 1Department of Medicine, University Hospital, Geneva, Switzerland.

Insights

Anticardiolipin antibodies (ACA) were found exclusively in HIV-infected hemophiliacs. However, ACA presence did not correlate with disease progression in this patient group.

Area of Science:

  • Immunology
  • Hematology
  • Virology

Background:

  • Hemophilia is a bleeding disorder often requiring frequent blood transfusions.
  • Human Immunodeficiency Virus (HIV) infection can affect various bodily systems.
  • Anticardiolipin antibodies (ACA) are autoantibodies associated with thrombotic events.

Purpose of the Study:

  • To investigate the prevalence of anticardiolipin antibodies (ACA) in heavily transfused hemophiliacs.
  • To determine the association between ACA and HIV infection in hemophiliacs.
  • To explore the relationship between ACA and disease progression in HIV-infected hemophiliacs.

Main Methods:

  • Blood samples were collected from 72 hemophiliacs (43 HIV-positive, 29 HIV-negative).
  • Anticardiolipin antibodies (ACA) were measured using serological tests.
  • Patients were categorized based on HIV infection status and clinical stage (CDC II, III, IV).

Main Results:

  • ACA were detected in 10 patients, all of whom were HIV-positive.
  • ACA prevalence was 0% in HIV-negative hemophiliacs and 23.3% (10/43) in HIV-positive hemophiliacs.
  • No statistically significant difference in other laboratory markers was observed between ACA-positive and ACA-negative HIV-infected patients.
  • ACA presence was not associated with disease progression (AIDS) in HIV-infected hemophiliacs.

Conclusions:

  • Anticardiolipin antibodies are specifically found in HIV-infected hemophiliacs.
  • ACA detection in this cohort is linked to HIV infection, not hemophilia itself.
  • The presence of ACA does not appear to predict or influence the progression of HIV/AIDS in hemophiliac patients.